(Nasdaq: SPRC) ("Company” or "SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Study Finds on MSN
What Works at 50 May Backfire at 70: New Aspirin-Cancer Study Challenges Conventional Wisdom
In A Nutshell Starting aspirin after age 70 did not prevent cancer in a study of nearly 20,000 older adults followed for ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult?to?treat bacterial infections, today ...
GoodRx , the leading platform for prescription savings in the U.S., today announced it has earned its 2026 certification status for HITRUST i1 Certification for its prescription savings platform ...
Management to Engage with Global Clinical Research Leaders Ahead of Phase 2a Trial of Concussion Treatment. Sarasota, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE ...
Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...
GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine )Collaboration designed to lower patient out-of-pocket costs and ...
India plans to place pregabalin under Schedule H1 to curb misuse. The move would mandate prescription-only sales, strict record-keeping, and tighter oversight while ensuring access for genuine ...
"My old millionaire boss picked a penny up off the workshop floor, handed it to me, and said, 'There's your wages,' then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results